Skip to content

Clinical trials

Phase 2/3 Heart Failure trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2/3 Country / region: Australia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20121
20151
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bayside Health1
Biotronik, Inc.1
Gilead Sciences1
LoneStar Heart, Inc.1
Wentworth Area Health Services1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure6
Angina Pectoris1
Cardiomyopathies1
Cardiomyopathy, Dilated1
Cardiomyopathy, Hypertrophic1
Cardiomyopathy, Hypertrophic, Familial1
Dyspnea1
Heart Diseases1
Hypertrophy1
Kidney Failure, Chronic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.